279 related articles for article (PubMed ID: 32759565)
21. Difficulties in laboratory diagnosis of coexistent lupus anticoagulant and factor VIII inhibitors: case report and review of literature.
Belhadj M; Cheikhrouhou M; Guermazi S
Ann Biol Clin (Paris); 2023 Oct; 81(4):417-423. PubMed ID: 37791505
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy.
Cugno M; Gualtierotti R; Tedeschi A; Meroni PL
Autoimmun Rev; 2014 Jan; 13(1):40-8. PubMed ID: 23954454
[TBL] [Abstract][Full Text] [Related]
23. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
24. ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome.
Yamada K; Nakajima Y; Ogiwara K; Sakai T; Fukuda K; Nogami K
Pediatr Int; 2024; 66(1):e15773. PubMed ID: 38863279
[TBL] [Abstract][Full Text] [Related]
25. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature.
Vivaldi P; Rossetti G; Galli M; Finazzi G
Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588
[TBL] [Abstract][Full Text] [Related]
26. A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies.
Tsukamoto Y; Sugimoto T; Umeda M; Kato T; Hiura Y; Morita K; Ariyoshi K
Intern Med; 2023 Jul; 62(14):2145-2149. PubMed ID: 36476549
[TBL] [Abstract][Full Text] [Related]
27. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
Murray D; Pennell B; Olson J
Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
[TBL] [Abstract][Full Text] [Related]
28. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.
Li R; Swaelens C; Vandermijnsbrugge F; Cantinieaux B
Eur J Haematol; 2016 Jun; 96(6):578-85. PubMed ID: 26179977
[TBL] [Abstract][Full Text] [Related]
29. [Exploration of hemostasis in current practice].
Aiach M; Gaussem P
Ann Pharm Fr; 1996; 54(1):21-4. PubMed ID: 8702189
[TBL] [Abstract][Full Text] [Related]
30. Screening and diagnosis of coagulation disorders.
Lusher JM
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):778-83. PubMed ID: 8828561
[TBL] [Abstract][Full Text] [Related]
31. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
Vinholt PJ; Nybo M
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
[TBL] [Abstract][Full Text] [Related]
32. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
Rasmussen KL; Philips M; Tripodi A; Goetze JP
Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
[TBL] [Abstract][Full Text] [Related]
33. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.
Mannucci PM; Canciani MT; Mari D; Meucci P
Scand J Haematol; 1979 May; 22(5):423-32. PubMed ID: 472662
[TBL] [Abstract][Full Text] [Related]
34. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
35. Lupus anticoagulant-hypoprothrombinemia in healthy adult.
Chung CH; Park CY
Korean J Intern Med; 2008 Sep; 23(3):149-51. PubMed ID: 18787368
[TBL] [Abstract][Full Text] [Related]
36. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
Kumano O; Moore GW
Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
[No Abstract] [Full Text] [Related]
37. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
38. Dramatically prolonged coagulation screening tests in a patient with positive lupus anticoagulant and monoclonal immunoglobulin M without bleeding manifestations.
Miloš M; Marijančević D; Kozmar A; Anić B; Coen Herak D
Clin Chim Acta; 2022 Jan; 525():6-11. PubMed ID: 34896061
[TBL] [Abstract][Full Text] [Related]
39. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
[TBL] [Abstract][Full Text] [Related]
40. Magnesium-dependent activated partial thromboplastin time assay-Simple method for lupus anticoagulant detection.
Tokutake T; Ieko M; Naito S; Yoshida M; Baba H; Kobayashi H; Ishida F
Int J Lab Hematol; 2020 Feb; 42(1):46-51. PubMed ID: 31821738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
